🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The purpose of this study was to combine the PDR001 checkpoint inhibitor wi...
Status
Completed
Location
UCLA Santa Monica Hematology / Oncology SC
Start Date
2016-10-14
Trial ID
NCT02890069
Treatments Being Tested
To determine and evaluate a safe and tolerated dose of HDM201 in adult pati...
Status
Completed
Location
Dana Farber Cancer Institute SC-6
Start Date
2014-07-07
Trial ID
NCT02143635
Treatments Being Tested
To determine the MTD/RP2D of the HDM201 and LEE011 combination and evaluate...
Status
Completed
Location
Novartis Investigative Site
Start Date
2015-03-13
Trial ID
NCT02343172
This study was to characterize the safety, tolerability, pharmacokinetics (...
Status
Terminated
Location
Columbia University Medical Center
Start Date
2016-02-01
Trial ID
NCT02601378
Treatments Being Tested
The purpose of this study was to investigate the safety, pharmacokinetics a...
Status
Terminated
Location
Novartis Investigative Site
Start Date
2019-09-26
Trial ID
NCT04097821
Treatments Being Tested
This was a phase 1b, multi-arm, open-label study of HDM201 in combination w...
Status
Terminated
Location
Duke University Medical Center .
Start Date
2019-06-24
Trial ID
NCT03940352
Treatments Being Tested
Recent preclinical studies suggest that combining MEK and MDM2 inhibition s...
Status
Completed
Location
Centre Leon Berard
Start Date
2018-12-20
Trial ID
NCT03714958
Treatments Being Tested
This is a multi-center open-label Phase I/II study investigating orally adm...
Status
Withdrawn
Location
Multiple Locations
Start Date
2019-11-15
Trial ID
NCT03760445
A study of siremadlin in combination with venetoclax plus azacitidine in ad...
Status
Completed
Location
Oregon Health Sciences University
Start Date
2022-05-17
Trial ID
NCT05155709
Treatments Being Tested
This is a non-randomized prospective open-label single-arm clinical phase I...
Status
Terminated
Location
Departement of Medical Oncology, University Hospital Berne
Start Date
2020-07-13
Trial ID
NCT04496999
Treatments Being Tested